Drug Class Review: Disease-modifying Drugs for Multiple Sclerosis

C. Borras, J. Rio, J. Porcel, M. Barrios, M. Tintore, X. Montalban, Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b Neurology. ,vol. 52, pp. 1636- 1636 ,(1999) , 10.1212/WNL.52.8.1636

M Calabrese, V Bernardi, M Atzori, I Mattisi, A Favaretto, F Rinaldi, P Perini, P Gallo, Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis Multiple Sclerosis Journal. ,vol. 18, pp. 418- 424 ,(2012) , 10.1177/1352458510394702

L Durelli, B Ferrero, A Oggero, E Verdun, M.R Bongioanni, E Gentile, G.L Isoardo, A Ricci, E Rota, B Bergamasco, M Durazzo, G Saracco, M.A Biava, P.C Brossa, L Giorda, R Pagni, G Aimo, Autoimmune events during interferon beta-1b treatment for multiple sclerosis. Journal of the Neurological Sciences. ,vol. 162, pp. 74- 83 ,(1999) , 10.1016/S0022-510X(98)00299-8

K Gottberg, A Gardulf, S Fredrikson, Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects. Multiple Sclerosis Journal. ,vol. 6, pp. 349- 354 ,(2000) , 10.1177/135245850000600510

DKB Li, GJ Zhao, DW Paty, University of British Columbia MS/MRI Analysis Research Group and the SPECTRIMS Study Group*, None, Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. Neurology. ,vol. 56, pp. 1505- 1513 ,(2001) , 10.1212/WNL.56.11.1505

Luca Durelli, B Ferrero, A Oggero, E Verdun, A Ghezzi, E Montanari, M Zaffaroni, Betaferon Safety Trial (BEST) Study Group, None, Liver and thyroid function and autoimmunity during interferon-β1b treatment for MS Neurology. ,vol. 57, pp. 1363- 1370 ,(2001) , 10.1212/WNL.57.8.1363

Hossein Kalanie, Kurosh Gharagozli, Abolfazl Hemmatie, Mehdie Ghorbanie, Amir Reza Kalanie, Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis in Iran European Neurology. ,vol. 52, pp. 202- 206 ,(2004) , 10.1159/000082036

M. B. Bornstein, A. Miller, S. Slagle, M. Weitzman, E. Drexler, M. Keilson, V. Spada, W. Weiss, S. Appel, L. Rolak, Y. Harati, S. Brown, R. Arnon, I. Jacobsohn, D. Teitelbaum, M. Sela, A placebo‐controlled, double‐blind, randomized, two‐center, pilot trial of Cop 1 in chronic progressive multiple sclerosis Neurology. ,vol. 41, pp. 533- 533 ,(1991) , 10.1212/WNL.41.4.533

Gert Van Assche, Marc Van Ranst, Raf Sciot, Bénédicte Dubois, Séverine Vermeire, Maja Noman, Jannick Verbeeck, Karel Geboes, Wim Robberecht, Paul Rutgeerts, Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease The New England Journal of Medicine. ,vol. 353, pp. 362- 368 ,(2005) , 10.1056/NEJMOA051586

Steven L. Galetta, Clyde Markowitz, Andrew G. Lee, Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review. JAMA Internal Medicine. ,vol. 162, pp. 2161- 2169 ,(2002) , 10.1001/ARCHINTE.162.19.2161